Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument | GenomeWeb

By Ben Butkus

Focus Diagnostics' next molecular diagnostic for the 3M Integrated Cycler will be a single test for seasonal influenza A, influenza B, and respiratory syncytial virus, a company executive said this week.

The test, which is expected to receive the European CE Mark in the next few weeks and has been submitted for regulatory approval in the US, would be the second under the company's Simplexa line of assays, established last year through an exclusive partnership inked between Focus and 3M.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.